Back to Search Start Over

Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

Authors :
Matthew Barth
Ana C. Xavier
Saro Armenian
Anthony N. Audino
Lindsay Blazin
David Bloom
Jong Chung
Kimberly Davies
Hilda Ding
James B. Ford
Paul J. Galardy
Rabi Hanna
Robert Hayashi
Cathy Lee-Miller
Andrea Judit Machnitz
Kelly W. Maloney
Lianna Marks
Paul L. Martin
David McCall
Martha Pacheco
Anne F. Reilly
Mikhail Roshal
Sophie Song
Joanna Weinstein
Sara Zarnegar-Lumley
Nicole McMillian
Ryan Schonfeld
Hema Sundar
Source :
Journal of the National Comprehensive Cancer Network. 20:1267-1275
Publication Year :
2022
Publisher :
Harborside Press, LLC, 2022.

Abstract

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Aggressive Mature B-Cell Lymphomas include recommendations for the diagnosis and management of pediatric patients with primary mediastinal large B-cell lymphoma (PMBL) and sporadic variants of Burkitt lymphoma and diffuse large B-cell lymphoma. PMBL is now considered as a distinct entity arising from mature thymic B-cells accounting for 2% of mature B-cell lymphomas in children and adolescents. This discussion section includes the recommendations outlined in the NCCN Guidelines for the diagnosis and management of pediatric patients with PMBL.

Details

ISSN :
15401413 and 15401405
Volume :
20
Database :
OpenAIRE
Journal :
Journal of the National Comprehensive Cancer Network
Accession number :
edsair.doi.dedup.....cbf67bc0a9329f1eb85467759ffae74d
Full Text :
https://doi.org/10.6004/jnccn.2022.0057